These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24762312)

  • 21. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.
    Weiskopf D; Angelo MA; Bangs DJ; Sidney J; Paul S; Peters B; de Silva AD; Lindow JC; Diehl SA; Whitehead S; Durbin A; Kirkpatrick B; Sette A
    J Virol; 2015 Jan; 89(1):120-8. PubMed ID: 25320311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
    Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
    J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research progress in the structure and function of dengue virus non-structural 1 protein].
    Chen Y; Ren RW; Liu JW
    Bing Du Xue Bao; 2014 Nov; 30(6):683-8. PubMed ID: 25868284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine.
    Lim HX; Lim J; Poh CL
    Med Microbiol Immunol; 2021 Feb; 210(1):1-11. PubMed ID: 33515283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.
    Glasner DR; Puerta-Guardo H; Beatty PR; Harris E
    Annu Rev Virol; 2018 Sep; 5(1):227-253. PubMed ID: 30044715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design.
    Falconar AK
    Clin Vaccine Immunol; 2007 May; 14(5):493-504. PubMed ID: 17329445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.
    Mathew A; Kurane I; Green S; Stephens HA; Vaughn DW; Kalayanarooj S; Suntayakorn S; Chandanayingyong D; Ennis FA; Rothman AL
    J Virol; 1998 May; 72(5):3999-4004. PubMed ID: 9557687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.
    de Alwis R; Bangs DJ; Angelo MA; Cerpas C; Fernando A; Sidney J; Peters B; Gresh L; Balmaseda A; de Silva AD; Harris E; Sette A; Weiskopf D
    J Virol; 2016 May; 90(9):4771-4779. PubMed ID: 26912627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
    Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
    J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection.
    Martinez DR; Metz SW; Baric RS
    Cell Host Microbe; 2021 Jan; 29(1):13-22. PubMed ID: 33444553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.
    Hurtado-Melgoza ML; Ramos-Ligonio A; Álvarez-Rodríguez LM; Meza-Menchaca T; López-Monteon A
    J Biomed Sci; 2016 Dec; 23(1):85. PubMed ID: 27903271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
    Hussain M; Idrees M; Afzal S
    Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
    Hughes HR; Crill WD; Davis BS; Chang GJ
    Virology; 2012 Mar; 424(2):129-37. PubMed ID: 22244913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.